Components of a complex substance
Pharmacological Group
Latin name
Lidocainum + Neomycinum + Polymyxinum в ( Lidocaini + Neomycini + Polymyxini в).
Used in the treatment of
- H66.9 Otitis media, unspecified
- H66.4 Suppurative otitis media, unspecified
- H60.9 Otitis externa, unspecified
- Y83.8 Abnormal reaction/later complication, without mention of misadventure at the time of the procedure, other surgical procedures
- H95.8 Other postprocedural disorders of ear and mastoid process
Analogs by action
- 75% Neomycin+Nystatin+Polymyxin B [Neomycin and more 2Nystatin, Polymyxin B]
- 73% Bacitracin+Neomycin+Polymyxin B [Neomycin and more 2Polymyxin B, Bacitracin]
- 69% Neomycin+Fluocinolone acetonide+Lidocaine [Neomycin and more 2Fluocinolone acetonide, Lidocaine]
- 62% Dexamethasone+Neomycin+Polymyxin B [Dexamethasone and more 2Neomycin, Polymyxin B]
- Show all
Included in the composition
- 3.7-4.7€ Anauran (Zambon S.P.A. )